FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+12.44%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$620M
AUM Growth
+$620M
(-3.5%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-19.18%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
63
New
8
Increased
6
Reduced
34
Closed
4
Top Buys
| 1 |
XENT
Intersect ENT, Inc
XENT
|
$8.32M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$5.74M |
| 3 |
Veracyte
VCYT
|
$2.92M |
| 4 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
$2.43M |
| 5 |
CLLS
Cellectis
CLLS
|
$2.15M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$70.3M |
| 2 |
NeoGenomics
NEO
|
$22.4M |
| 3 |
AtriCure
ATRC
|
$14.4M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$13.6M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$9.28M |
Sector Composition
| 1 | Healthcare | 83.6% |
| 2 | Communication Services | 3.41% |
| 3 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
26
DELISTED
LHC Group LLC
LHCG
| $5.56M | 0.9% |
53,947
-413
| -0.8% | -$42.5K |
|
27
Bio-Techne
TECH
$8.3B
| $5.15M | 0.83% |
25,216
-15,873
| -39% | -$3.24M |
|
|
BLUE
28
DELISTED
bluebird bio
BLUE
| $4.85M | 0.78% |
33,217
-143
| -0.4% | -$20.8K |
|
29
Vertex Pharmaceuticals
VRTX
$102B
| $4.78M | 0.77% |
24,787
-187
| -0.7% | -$36K |
|
|
TLGT
30
DELISTED
Teligent, Inc
TLGT
| $4.52M | 0.73% |
1,145,096
-5,936
| -0.5% | -$23.4K |
|
31
OrthoPediatrics
KIDS
$524M
| $4.52M | 0.73% |
123,241
-867
| -0.7% | -$31.8K |
|
32
Sangamo Therapeutics
SGMO
$161M
| $4.51M | 0.73% |
265,877
+110,529
| +71% | +$1.87M |
|
|
NXTM
33
DELISTED
NxStage Medical Inc.
NXTM
| $4.22M | 0.68% |
151,207
-1,241
| -0.8% | -$34.6K |
|
34
QuidelOrtho
QDEL
$1.87B
| $3.58M | 0.58% |
54,878
-25,877
| -32% | -$1.69M |
|
35
HealthStream
HSTM
$832M
| $2.82M | 0.46% |
90,986
-649
| -0.7% | -$20.1K |
|
36
iShares Biotechnology ETF
IBB
$5.68B
| $2.6M | 0.42% |
21,291
| – | – |
|
|
37
Invesco S&P SmallCap Health Care ETF
PSCH
$145M
| $2.43M | 0.39% |
+17,285
| New | +$2.43M |
|
|
CLLS
38
Cellectis
CLLS
$260M
| $2.15M | 0.35% |
+76,325
| New | +$2.15M |
|
39
LeMaitre Vascular
LMAT
$2.14B
| $1.92M | 0.31% |
49,617
-379
| -0.8% | -$14.7K |
|
40
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $1.74M | 0.28% |
18,241
| – | – |
|
41
iShares US Medical Devices ETF
IHI
$4.27B
| $1.72M | 0.28% |
7,580
| – | – |
|
42
Alkermes
ALKS
$4.95B
| $1.36M | 0.22% |
32,032
-239
| -0.7% | -$10.1K |
|
43
Simulations Plus
SLP
$289M
| $1.16M | 0.19% |
+57,548
| New | +$1.16M |
|
44
Catheter Precision
VTAK
$3.12M
| $1.09M | 0.18% |
60,000
+60,000
| – | – |
|
|
ENZ
45
DELISTED
Enzo Biochem, Inc.
ENZ
| $775K | 0.13% |
188,159
-1,441
| -0.8% | -$5.94K |
|
46
AbbVie
ABBV
$374B
| $393K | 0.06% |
4,159
| – | – |
|
47
Pfizer
PFE
$141B
| $377K | 0.06% |
8,558
| – | – |
|
|
DYNT
48
DELISTED
Dynatronics Corp
DYNT
| $316K | 0.05% |
110,811
+1,926
| +2% | +$5.49K |
|
49
Novartis
NVS
$248B
| $308K | 0.05% |
3,572
| – | – |
|
50
Merck
MRK
$210B
| $305K | 0.05% |
4,294
| – | – |
|